Drug Information

Drug General Information
Drug ID
D0Q3PD
Former ID
DCL001234
Drug Name
S-297995
Drug Type
Small molecular drug
Indication Opioid induced adverse effect [ICD9: 304; ICD10:F11] Phase 2 [551683]
Company
Shionogi
Structure
Download
2D MOL

3D MOL
Formula
C32H34N4O6
Canonical SMILES
CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C<br />3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O
InChI
1S/C32H34N4O6/c1-30(2,29-33-27(35-42-29)18-6-4-3-5-7-18)34-28(39)20-15-32(40)22-14-19-10-11-21(37)25-23(19)31(32,26(41-25)24(20)38)12-13-36(22)16-17-8-9-17/h3-7,10-11,17,22,26,37-38,40H,8-9,12-16H2,1-2H3,(H,34,39)/t22-,26+,31+,32-/m1/s1
InChIKey
AXQACEQYCPKDMV-RZAWKFBISA-N
PubChem Compound ID
54732242
PubChem Substance ID
124344734, 135249765, 135626906, 137778962, 160681958, 198941634, 235237778
Target and Pathway
Target(s) Opioid receptor Target Info Antagonist [551683]
References
Ref 551683Clinical pipeline report, company report or official report of Shionogi (2011).
Ref 551683Clinical pipeline report, company report or official report of Shionogi (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.